INmune Bio reports 2025 financial results, plans regulatory filings

Go back to INmune Bio reports 2025 financial results, plans regulatory filings
(NASDAQ: INMB) Delayed: 1.43 --0 (-0%)
Previous Close $1.43    52 Week High
Open $1.43    52 Week Low
Day High $1.43    P/E N/A 
Day Low $1.43    EPS
Volume 6,250